Body composition research.

Body composition and metabolic research has become one of the fastest moving areas in peptide literature, largely on the back of incretin family research. Apothify catalogs three distinct families here. Incretin and gut hormones (GLP-1, GIP, the glucagon family, PYY 3-36) are studied for satiety and glucose research. Growth hormone fragments (AOD-9604, HGH Fragment 176-191, Frag 191-227) are studied for lipid metabolism research. A smaller set of compounds (MOTS-c, 5-Amino-1MQ, Adipotide) is studied around mitochondrial and NNMT pathway research.

The incretin family is where most current published research is concentrated. GLP-1 receptor agonist research has produced an extensive published literature on satiety signaling, glucose dependence, and pancreatic beta cell behavior in research models. Many of the compounds in this family overlap mechanistically and the Compare tool flags those overlaps. Pairing two GLP-1 receptor agonists in the same research model is typically redundant rather than additive.

Body composition is also the category where the gap between research framing and consumer interest is most visible. Many of these compounds have well publicized therapeutic uses in regulated markets. The Apothify library frames every entry in research terms only. Entries with established prescription status appear as encyclopedia coverage with no commerce pathway, marked clearly in each product module.